Corleen Roche
Förmögenhet: 385 265 $ per 2026-08-31
Förmögenhet: 385 265 $ per 2026-08-31
Corleen M.
Roche is currently Chief Financial Officer at Iovance Biotherapeutics, Inc. since 2025.
Formerly, Ms. Roche was Secretary, Chief Financial & Accounting Officer at CG Oncology, Inc. from 2024 to 2025; Chief Financial & Accounting Officer at Immunome, Inc. from 2021 to 2024; Chief Financial Officer at Biogen, Inc. from 2019 to 2021; Chief Financial Officer at Sandoz, Inc. from 2015 to 2019.
Ms. Roche also held Chief Financial Officer roles at Iogenetics LLC, CSL Behring LLC, Wyeth Pharmaceuticals, Inc., and Pfizer Inc. Ms. Roche completed undergraduate education at Villanova University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-06 | 28 757 ( 0,01 % ) | 234 945 $ | 2026-08-31 | |
| 2026-03-01 | 2 000 ( 0 % ) | 150 320 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Finansdirektör/CFO | 2025-08-06 |
| Företag | Position | Slut |
|---|---|---|
| CG ONCOLOGY, INC. | Finansdirektör/CFO | 2025-08-05 |
| IMMUNOME, INC. | Finansdirektör/CFO | 2024-01-02 |
| BIOGEN INC. | Finansdirektör/CFO | 2021-04-01 |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Finansdirektör/CFO | 2019-01-01 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Finansdirektör/CFO | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Iogenetics LLC
Iogenetics LLC Miscellaneous Commercial ServicesCommercial Services Develops proprietary antimicrobial proteins and immunogenetics solutions | Commercial Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
CG Oncology, Inc.
CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån